Richard Bartram
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Richard Bartram
Earlier roles on record: CFO at MBX Biosciences, Inc. (MBX) until March 15, 2026. MBX Biosciences, Inc. reported in an 8-K filed February 27, 2026 that Richard Bartram resigned as Chief Financial Officer, effective March 15, 2026. The proxy statement of MBX Biosciences, Inc. reports total compensation of $1,496,275 for Richard Bartram in fiscal 2025, including a base salary of $484,000. Disclosed compensation is on record for 3 fiscal years.
“On February 25, 2026, the Company and Richard Bartram entered into a separation agreement pursuant to which Mr. Bartram will resign as Chief Financial Officer of the Company. He will continue his employment with the Company as its Chief Financial Officer through March 15, 2026.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Start not stated–2026-03-15
Company network
Recorded roles and call appearances connecting this person to public companies.
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | MBX Biosciences, Inc. (MBX) | Former Chief Financial Officer | $484,000 | $1,496,275 |
| 2024 | MBX Biosciences, Inc. (MBX) | Chief Financial Officer | $442,000 | $1,153,568 |
| 2023 | MBX Biosciences, Inc. (MBX) | Chief Financial Officer | $425,000 | $1,051,106 |
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.